News Search Results
Nov 18, 2025, 08:30 ET Biomarker Testing: Pushing the Limits of Ultrasensitivity, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Nov 18, 2025, 08:05 ET INOVIO to Participate in December Investor Conferences
PLYMOUTH MEETING, Pa., Nov. 18, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Nov 18, 2025, 08:00 ET Mabloc and Instituto Butantan Partner to Advance First-in-Class Antibody Therapy for Yellow Fever
WASHINGTON and SÃO PAULO, Nov. 18, 2025 /PRNewswire/ -- Mabloc, a biotechnology company developing monoclonal antibody therapies for multiple disease indications, today announced a strategic partnership with Instituto Butantan,
More news about: Mabloc
Nov 18, 2025, 08:00 ET Vasa Therapeutics Granted FDA Fast Track Designation for VS-041, a Novel Investigational Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
WROCLAW, Poland, Nov. 18, 2025 /PRNewswire/ -- Vasa Therapeutics ("Vasa"), a private, clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, today announced that the U.S. Food and Drug Administration (FDA) has
More news about: Vasa Therapeutics
Nov 18, 2025, 08:00 ET Nudge Security Raises $22.5M Series A to Secure Workforce AI and SaaS
include forward-thinking IT and security teams at cloud-native organizations spanning software, financial services, healthcare, biotechnology, entertainment, and more. "Nudge Security has been a big win for our security program at Reddit," says Fredrick Lee, CISO
More news about: Nudge Security
Nov 18, 2025, 07:00 ET Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST
Nov. 18, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Nov 18, 2025, 07:00 ET Vincere Biosciences Awarded $5 Million from The Michael J. Fox Foundation to Advance Parkinson's Therapeutic Toward Clinical Trials
Vincere. About Vincere Biosciences Inc. Vincere Biosciences is a Boston-based biotechnology company developing small-molecule therapeutics that improve mitochondrial repair and recycling to address neurodegeneration and age-related conditions.
More news about: Vincere Biosciences
Nov 18, 2025, 06:30 ET Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
Monod Bio, a Seattle-based biotechnology company spun out from the Nobel Prize-winning David Baker lab at the University of Washington, Institute for Protein Design. The agreement grants
More news about: Bio-Techne Corporation
Nov 18, 2025, 05:40 ET Oncology Molecular Diagnostics Market to Reach US$ 6.46 Billion by 2033, Driven by Precision Oncology, and Accelerating Biomarker-Based Therapies - According to DataM Intelligence
DataM Intelligence is a global market research and consulting firm delivering actionable insights across healthcare, biotechnology, pharmaceuticals, and life sciences industries. With continuous database updates, in-depth competitive intelligence, and 360-degree market coverage,
More news about: DataM Intelligence 4 Market Research LLP
Nov 18, 2025, 05:17 ET Biosensors Market Dominated by Electrochemical Sensors with 72% Revenue Share, as Global Biosensors Market Size is set to Surpass USD 42B by 2030, Says Mordor Intelligence
technological advancements in diagnostic tools and increased adoption of wearable health devices. The market is further benefiting from the convergence of biotechnology, nanotechnology, and electronics, enabling faster, miniaturized, and more sensitive biosensing systems across healthcare, food safety, and environmental
More news about: Mordor Intelligence Private Limited
Nov 18, 2025, 04:03 ET OCHRE BIO COMPLETES HUMAN LIVER FUNCTIONAL GENOMICS AND SINGLE-CELL DATASETS IN PARTNERSHIP WITH GSK
OXFORD, England, Nov. 18, 2025 /PRNewswire/ -- Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, today announced the successful completion of the research phase of its collaboration
More news about: Ochre Bio
Nov 18, 2025, 04:00 ET CRScube acquires Mednet to expand global eClinical capabilities
The companies bring deep expertise in Software as a Service (SaaS), trusted by sponsors and CROs in pharmaceuticals, biotechnology, and medical devices. CRScube is Korea's #1 eClinical provider, having supported 6,000+ trials worldwide and recognized on G2.com for the highest
More news about: CRScube
Nov 18, 2025, 03:55 ET Smart Manufacturing Market Set to Hit US$1,097.26 Bn by 2035 with Robust 15.25% CAGR Growth | Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Nov 18, 2025, 02:53 ET By Popular Demand CS Analytical Hosting Q&A Webinar on USP 661.1 and USP 661.2
and inspected contract laboratory exclusively designed and dedicated to the regulated container and package testing needs of the pharmaceutical, biotechnology, and medical device industries is pleased to announce that it will be hosting an additional Question and Answer Session webinar on current requirements
More news about: CS Analytical
Nov 17, 2025, 11:00 ET American Cancer Society Launches Nationwide Program to Increase Equity in Clinical Trials
social needs screening, and the opportunity to explore clinical trial matching. If the decision is made to move forward with matching, collaborating biotechnology company Massive Bio provides a personalized artificial intelligence (AI) matched list of eligible cancer clinical trials sourced through
More news about: American Cancer Society
Nov 17, 2025, 10:50 ET LED Operating Light Market Surges to USD 3.2 Billion by 2033, Propelled by 9.2% CAGR - Verified Market Reports®
(Preclinical Services, Clinical Trial Management), By Therapeutic Indications (Hematologic Cancers, Solid Tumors), By End-Users (Pharmaceutical Companies, Biotechnology Firms), By Geographic Scope And Forecast About Us Verified
More news about: Verified Market Reports
Nov 17, 2025, 10:45 ET Pharmaceutical Quality Management Software Market worth $2.98 billion by 2030 with 13.3% CAGR | MarketsandMarkets™
support needed to seamlessly integrate Generative AI (GenAI) solutions with Veeva Vault applications. Regarding collaboration, pharmaceutical and biotechnology companies are increasingly partnering to expand pharmaceutical quality management software infrastructure and reach. A notable example is the July
More news about: MarketsandMarkets
Nov 17, 2025, 10:45 ET Electronic Data Capture Software Market is expected to generate a revenue of USD 4.06 Billion by 2031, Globally, at 14.5% CAGR: Verified Market Research®
Investments and Expansion of Clinical Trial Pipelines Pharmaceutical, biotechnology, and medical device companies are significantly increasing their R&D budgets, driving demand for efficient data capture and real-time analytics
More news about: Verified Market Research
Nov 17, 2025, 09:26 ET Breakthrough Properties Raises $430 Million to Propel Next Phase of Growth
around the world and support scientific innovation across biotechnology, agriculture, and nutrition. Breakthrough combines Tishman Speyer's decades of global real estate development experience with Bellco Capital's industry-making biotechnology entrepreneurship to reimagine environments where companies
More news about: Breakthrough Properties
Nov 17, 2025, 09:16 ET MLTX DEADLINE REMINDER: Berger Montague Reminds MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors of Important Class Action Lawsuit Deadline
CLICK HERE . MoonLake is a clinical-stage biotechnology company headquartered in Zug, Switzerland. According to the lawsuit, MoonLake and certain executives made false and misleading
More news about: Berger Montague
Nov 17, 2025, 09:15 ET Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs
BOSTON, Nov. 17, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. ("Bambusa"), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of its oversubscribed
More news about: Bambusa Therapeutics, Inc.
Nov 17, 2025, 09:00 ET Breakthrough Properties Raises $430 Million to Propel Next Phase of Growth
around the world and support scientific innovation across biotechnology, agriculture, and nutrition. Breakthrough combines Tishman Speyer's decades of global real estate development experience with Bellco Capital's industry-making biotechnology entrepreneurship to reimagine environments where companies
More news about: Breakthrough Properties
Nov 17, 2025, 08:56 ET Oramed Reports Fiscal Third Quarter 2025 Financial Results
clinical trials and product development programs; difficulties or delays in obtaining regulatory approval; competition from other pharmaceutical or biotechnology companies; market volatility affecting our investment portfolio; our ability to realize expected returns from Scilex and other investments; and
More news about: Oramed Pharmaceuticals Inc.
Nov 17, 2025, 08:50 ET ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS
clinical trials and product development programs; difficulties or delays in obtaining regulatory approval; competition from other pharmaceutical or biotechnology companies; market volatility affecting our investment portfolio; our ability to realize expected returns from Scilex and other investments; and
More news about: Oramed Pharmaceuticals Inc.
Nov 17, 2025, 08:15 ET Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the International Nonproprietary Names (INN) Expert Committee of
More news about: Anixa Biosciences, Inc.